Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data BEYOND MEAT, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
32.6
87.9
298
407
465
419
343
326
275
Cost of revenue
34.8
70.4
198
285
347
443
426
285
268
Gross profit
-2.19
17.6
99.8
122
117
-23.7
-82.7
41.7
7.65
Research and development
5.72
9.59
20.7
31.5
66.9
62.3
39.5
28.1
23.2
Selling, general and administrative
17.1
34.5
74.7
134
209
240
204
170
218
Operating expenses
26.4
45.6
100
172
292
319
259
198
341
Operating income
-28.6
-28
-0.49
-49.3
-175
-343
-342
-156
-334
Interest expense
1
1.13
3.07
2.58
3.65
3.97
3.96
4.1
14
Other non-operating income
-1.81
-1.9
-11.9
-3.34
-4.14
-4.39
7.66
-4.11
553
Pre-tax income
-30.4
-29.9
-12.4
-52.7
-179
-347
-334
-160
219
Income tax
0.01
0
0.01
0.07
0.06
0.03
0.01
-0.03
0
Net income
-30.4
-29.9
-12.4
-52.8
-182
-366
-338
-160
219
EBITDA
-25.4
-23.1
7.62
-36
-153
-310
-294
-133
-301
EPS, basic
-5.57
-4.75
-0.29
-0.85
-2.88
-5.75
-5.26
-2.43
1.15
EPS, diluted
-5.57
-4.75
-0.29
-0.85
-2.88
-5.75
-5.26
-2.43
-1.83
Shares, basic (weighted)
5.46
6.29
42.3
62.3
63.2
63.6
64.3
66
155
Shares, diluted (weighted)
5.46
6.29
42.3
62.3
63.2
63.6
64.3
66
181
Balance sheet
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
39
54.3
276
159
733
310
191
132
204
Receivables
12.6
40.1
36
43.8
34.2
31.7
26.9
26.1
Inventory
30.3
81.6
122
242
236
130
113
84
Other current assets
5.67
5.93
15.4
33.1
20.7
12.9
11.3
13.8
Total current assets
103
404
332
1,052
606
373
286
341
Property, plant and equipment
30.5
47.5
115
226
257
194
185
213
Lease right-of-use assets
14.6
26.8
87.6
130
124
5.66
Other non-current assets
0.4
0.86
5.91
6.84
10.7
1.19
0.62
2.6
Total assets
134
452
468
1,379
1,062
774
678
615
Accounts payable
17.2
26.9
53.1
69
55.3
56
37.6
20.5
Accrued liabilities
2.39
3.81
4.83
20.7
16.7
9.86
11.7
8.98
Short-term debt
0
11
25
0
0
0
0
0
Total current liabilities
25.2
47.7
89
94.2
75.8
74.4
61.5
74.9
Long-term debt
30.4
19.6
0
1,130
1,134
1,138
1,141
416
Lease liabilities
11.8
22.6
55.9
75.6
73.6
4.06
Other non-current liabilities
0.57
0.15
0.44
0.47
0.27
0
0.22
Total liabilities
255
67.8
101
1,247
1,266
1,288
1,279
616
Total debt
30.4
30.6
25
1,130
1,134
1,138
1,141
416
Paid-in capital
7.92
526
560
510
544
573
644
1,029
Retained earnings
-130
-142
-195
-377
-743
-1,081
-1,242
-1,023
Other comprehensive income
0
1.75
-0.55
-4.8
-5.25
-3.69
-7.84
Shareholders' equity
-95.9
-122
384
367
132
-204
-513
-601
-1
Total equity
-95.9
-122
384
367
132
-204
-513
-601
-1
Total liabilities and equity
134
452
468
1,379
1,062
774
678
615
Shares outstanding
6.95
61.6
62.8
63.4
63.8
64.6
76.1
454
Cash flow statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-30.4
-29.9
-12.4
-52.8
-182
-366
-338
-160
219
Depreciation and amortization
3.18
4.92
8.11
13.3
21.7
32.6
48.1
23.1
32.8
Stock-based compensation
0.67
2.24
12.8
27.3
27.7
33.9
29.1
23.9
31
Deferred income tax
0
0
0
0
0
0
0
0
0
Change in receivables
-2.7
-9.05
-27.5
4.52
-8.46
9.06
2.72
4.19
1.65
Change in inventory
-1.96
-22.1
-51.3
-38.9
-123
2.57
106
15.6
31.7
Change in payables
2.36
10.5
10.1
16
21.7
-10.8
3
-20.6
-15.2
Cash from operations
-25.3
-37.7
-47
-40
-301
-320
-108
-98.8
-145
Capital expenditures
-7.91
-22.2
-23.8
-57.7
-136
-70.5
-10.6
-11
-12.3
Cash from investing
-8.12
-23.2
-26.2
-74.9
-147
-87.5
-9.49
-6.23
-10.3
Stock issued
0
0
37.4
0
0
0
0
46.7
149
Share buybacks
0
-0.51
0
0
Cash from financing
55.4
76.2
295
-1.76
1,022
0.28
-0.55
45.8
223
Net change in cash
22
15.2
222
-117
573
-407
-118
-59.3
68.2
Free cash flow
-33.2
-59.9
-70.8
-97.7
-437
-391
-118
-110
-157
Interest paid
0.27
0.92
3.02
2.56
0.35
0.01
0
0
0
Income taxes paid
0
0
0.01
0.02
-0.01
0.04
-0
0.01
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $8.35 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
5.6%
Gross profit / revenue.
Operating margin
-117.3%
Operating income / revenue.
EBITDA margin
-105.5%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
111.7%
Pre-tax income / revenue.
Net margin
115.9%
Net income / revenue.
FCF margin
-46.4%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-42.5%
Cash from operations / revenue.
Effective tax rate
0.0%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
528.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
53.6%
Net income / average total assets.
Return on invested capital (ROIC)
-145.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
7.5%
Research and development expense / revenue.
SG&A / revenue
78.3%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
13.4%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
3.8%
Capital expenditures / revenue.
D&A / revenue
11.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-15.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-13.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-7.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-81.7%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 5y
-42.6%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-9.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-16.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
5.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
174.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
41.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
23.8%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.63x
Current assets / current liabilities.
Quick ratio
1.76x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.53x
(Cash + short-term investments) / current liabilities.
Debt / equity
5.70x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
57.8%
Total debt / total assets.
Liabilities / assets
89.9%
Total liabilities / total assets.
Net debt
$152.4M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
FCF conversion
-40.0%
Free cash flow / net income, when net income is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.51
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.44
Revenue / diluted weighted shares.
FCF per share
-$0.20
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.19
Cash from operations / diluted weighted shares.
Book value per share
$0.11
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
0.48x
Market cap / net income. Only when net income is positive.
P/S
0.55x
Market cap / revenue.
P/B
2.53x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.53x
Market cap / tangible book value, when positive.
EV/Sales
1.14x
Enterprise value / revenue.
FCF yield
-83.6%
Free cash flow / market cap.
Earnings yield
208.9%
Net income / market cap (the inverse of P/E).
What was BEYOND MEAT, INC.'s revenue in fiscal 2025?
BEYOND MEAT, INC. reported revenue of $275.5M for fiscal 2025, 15.6% lower than the year before.
Was BEYOND MEAT, INC. profitable in fiscal 2025?
Yes. Net income was $219.0M, a net margin of 79.5%.
How much free cash flow did BEYOND MEAT, INC. generate in fiscal 2025?
Cash from operations of $144.9M minus capital expenditures of $12.3M left free cash flow of -$157.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.